Back to articles
Comparative guide · 7 min read

Ashwagandha vs Rhodiola vs Cordyceps — three adaptogens compared

Updated 2026-05-02 · Reviewed by SupplementScore editors · No sponsorships

"Adaptogen" is a marketing word as much as a pharmacological one — the umbrella covers a hundred herbs with very different mechanisms. The three below are the most-bought, most-studied, and most often confused for each other. They are not interchangeable.

Quick verdict

GoalBest-fit adaptogenWhy
Chronic stress, anxiety, sleep quality Ashwagandha Largest RCT base for stress and anxiety endpoints; meaningful cortisol-lowering at trial-validated doses (KSM-66 600 mg/day).
Acute mental fatigue, jet-lag, exam-week stamina Rhodiola Activating rather than calming. Several short-duration trials show modest benefit for fatigue and stress in people without baseline pathology.
Aerobic performance, VO2max Cordyceps (militaris) Effect sizes are small but reasonably consistent in trained subjects. Not a calming herb at all.
"I don't know which one I need" Probably ashwagandha Best-supported, broadest applicability, lowest cost. Start there before exploring the others.

How they actually work

Ashwagandha (Withania somnifera) — the calming adaptogen

Active compounds are a family called withanolides. The two extracts with most clinical research are KSM-66 (root only, ≥5% withanolides) and Sensoril (root and leaf, higher withanolide concentration). Most stress and anxiety RCTs use one of those two — generic powdered ashwagandha varies enormously in withanolide content and is not equivalent.

Mechanism is not fully understood but includes GABAergic activity, modulation of HPA-axis output (lowering cortisol response to chronic stress), and effects on thyroid function. Best-supported endpoints: perceived stress, anxiety scores (HAM-A), sleep quality, and exercise recovery. Modest, replicated benefits on testosterone in men with low baseline values.

Rhodiola (Rhodiola rosea) — the activating adaptogen

Active compounds are rosavins and salidroside. Standardised extracts (typically 3% rosavins, 1% salidroside) are what trial protocols use. Mechanism includes monoamine modulation and mild MAO-B inhibition — the latter is part of why it feels stimulating rather than sedating.

Best-supported endpoints: subjective fatigue and burnout scores (in healthy stressed adults), short-term mental performance under fatigue, and mild depressive symptoms (smaller evidence base). Effect sizes are modest. Often misadvertised as "calming" — it isn't, and many users find it disrupts sleep if taken late.

Cordyceps (Cordyceps militaris) — the performance adaptogen

Active compounds include cordycepin and adenosine. Note: most modern clinical work uses cultivated Cordyceps militaris, not wild-harvested Cordyceps sinensis (which is rare, expensive, and ecologically unsustainable). The two are related but not identical; militaris is the one to buy.

Best-supported endpoint: aerobic exercise capacity (small but real improvements in VO2max and time-to-exhaustion in trained subjects taking 3+ g/day for 3+ weeks). The "energy" claims at lower casual-supplement doses are weak.

Practical rule. Match the adaptogen's profile to the deficit. Stressed and tired? Ashwagandha. Stressed and foggy? Rhodiola. Tired only when training? Cordyceps. Don't stack all three in a single capsule and hope for "synergy" — that's a marketing concept, not a clinical one.

Time to effect

Side-effect and contraindication profile

The brand-quality problem

Adaptogens are particularly susceptible to identity-and-potency problems in the supply chain. Ashwagandha root powder often gets adulterated with cheaper plant material; rhodiola is frequently substituted with cheaper Asian rhodiola species that lack rosavins; cordyceps is often labelled militaris when it's actually a cheaper mycelium-on-grain product with unverified active content. For all three, buy from manufacturers that publish certificate-of-analysis data and ideally use named patented extracts (KSM-66, Sensoril, SHR-5) rather than generic powders.